Effect of β-Cell Toxins on Genetically Engineered Insulin-Secreting Cells
- 30 June 1997
- journal article
- Published by Elsevier BV in Journal of Autoimmunity
- Vol. 10 (3), 239-244
- https://doi.org/10.1006/jaut.1997.0130
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council
This publication has 19 references indexed in Scilit:
- Recurrence of Autoimmune Diabetes Mellitus in Recipients of Cadaveric Pancreatic GraftsThe New England Journal of Medicine, 1996
- Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: inhibition by Bcl-2Diabetologia, 1996
- EVIDENCE OF RECURRENT AUTOIMMUNITY IN HUMAN ALLOGENEIC ISLET TRANSPLANTATIONTransplantation, 1996
- Insulinoma cells in culture show pronounced sensitivity to alloxan-induced oxidative stressDiabetologia, 1995
- Developmental Gene Expression in the Human Fetal PancreasPediatric Research, 1994
- Streptozotocin Interactions with Pancreatic β Cells and the Induction of Insulin-Dependent DiabetesPublished by Springer Science and Business Media LLC ,1990
- Streptozotocin is not toxic to the human fetal B cellDiabetologia, 1989
- Sensitivity to Pentamidine but Resistance to Streptozotocin of Tumoral Insulin-Producing Cells (RINmSF Line)Pancreas, 1986
- Insulin secretion by fetal human pancreas in organ cultureDiabetologia, 1982
- Streptozotocin and alloxan induce DNA strand breaks and poly(ADP–ribose) synthetase in pancreatic isletsNature, 1981